150 related articles for article (PubMed ID: 34238151)
1. Prediction Mechanism of Nevadensin as Antibacterial Agent against
Shadrina AAN; Herdiyati Y; Wiani I; Satari MH; Kurnia D
Comb Chem High Throughput Screen; 2022; 25(9):1488-1497. PubMed ID: 34238151
[TBL] [Abstract][Full Text] [Related]
2. Potential Fatty Acid as Antibacterial Agent Against Oral Bacteria of Streptococcus mutans and Streptococcus sanguinis from Basil (Ocimum americanum): In vitro and In silico Studies.
Herdiyati Y; Astrid Y; Shadrina AAN; Wiani I; Satari MH; Kurnia D
Curr Drug Discov Technol; 2021; 18(4):532-541. PubMed ID: 32652913
[TBL] [Abstract][Full Text] [Related]
3. Potential Nevadensin from
Putri SA; Nur Shadrina AA; Julaeha E; Kurnia D
Comb Chem High Throughput Screen; 2023; 26(9):1746-1754. PubMed ID: 36200248
[TBL] [Abstract][Full Text] [Related]
4. Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of
Kurnia D; Hutabarat GS; Windaryanti D; Herlina T; Herdiyati Y; Satari MH
Drug Des Devel Ther; 2020; 14():2977-2985. PubMed ID: 32801638
[TBL] [Abstract][Full Text] [Related]
5. Bio-Mechanism Inhibitory Prediction of β-Sitosterol from Kemangi (
Evangelina IA; Herdiyati Y; Laviana A; Rikmasari R; Zubaedah C; Anisah ; Kurnia D
Adv Appl Bioinform Chem; 2021; 14():103-115. PubMed ID: 34188494
[TBL] [Abstract][Full Text] [Related]
6. Bio-Mechanism of Catechin as Pheromone Signal Inhibitor: Prediction of Antibacterial Agent Action Mode by In Vitro and In Silico Study.
Kurnia D; Ramadhanty ZF; Ardani AM; Zainuddin A; Dharsono HDA; Satari MH
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770790
[TBL] [Abstract][Full Text] [Related]
7. Potential of MurA Enzyme and GBAP in Fsr Quorum Sensing System as Antibacterial Drugs Target: In vitro and In silico Study of Antibacterial Compounds from Myrmecodia pendans.
Apriyanti E; Satari MH; Kurnia D
Comb Chem High Throughput Screen; 2021; 24(1):109-118. PubMed ID: 32598250
[TBL] [Abstract][Full Text] [Related]
8. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
9. Identification and Molecular Docking Studies of Bioactive Principles from Alphonsea madraspatana Bedd. against Uropathogens.
Sahu A; Ghosh G; Rath G
Curr Pharm Biotechnol; 2020; 21(7):613-625. PubMed ID: 31914910
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial Flavonoids Against Oral Bacteria of Enterococcus Faecalis ATCC 29212 from Sarang Semut (Myrmecodia pendans) and Its Inhibitor Activity Against Enzyme MurA.
Kurnia D; Apriyanti E; Soraya C; Satari MH
Curr Drug Discov Technol; 2019; 16(3):290-296. PubMed ID: 30152286
[TBL] [Abstract][Full Text] [Related]
11. Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents:
Shinde AD; Nandurkar YM; Bhalekar S; Walunj YS; Ugale S; Ahmad I; Patel H; Chavan AP; Mhaske PC
J Biomol Struct Dyn; 2024; 42(3):1191-1207. PubMed ID: 37254438
[TBL] [Abstract][Full Text] [Related]
12. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
[TBL] [Abstract][Full Text] [Related]
13. Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India.
Kumar M; Dahiya S; Sharma P; Sharma S; Singh TP; Kapil A; Kaur P
PLoS One; 2015; 10(5):e0126560. PubMed ID: 25962113
[TBL] [Abstract][Full Text] [Related]
14. The Potential of 24-Propylcholestrol as Antibacterial Oral Bacteria of
Windaryanti D; Gabriel CS; Hidayat IW; Zainuddin A; Dharsono HDA; Satari MH; Kurnia D
Adv Appl Bioinform Chem; 2022; 15():99-111. PubMed ID: 36578792
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
[TBL] [Abstract][Full Text] [Related]
16. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis.
Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
J Biomol Struct Dyn; 2018 Feb; 36(2):362-375. PubMed ID: 28071975
[TBL] [Abstract][Full Text] [Related]
18. Identification of secondary metabolites from Crescentia cujete as promising antibacterial therapeutics targeting type 2A topoisomerases through molecular dynamics simulation.
Aribisala JO; Abdulsalam RA; Dweba Y; Madonsela K; Sabiu S
Comput Biol Med; 2022 Jun; 145():105432. PubMed ID: 35344868
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors.
Salem MA; Ragab A; El-Khalafawy A; Makhlouf AH; Askar AA; Ammar YA
Bioorg Chem; 2020 Mar; 96():103619. PubMed ID: 32036161
[TBL] [Abstract][Full Text] [Related]
20. Characterisation and identification of antibacterial compound from marine actinobacteria: In vitro and in silico analysis.
Priyanka S; Jayashree M; Shivani R; Anwesha S; Bhaskara Rao KV; I AE
J Infect Public Health; 2019; 12(1):83-89. PubMed ID: 30270149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
